BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17560790)

  • 1. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.
    Manning-Boğ AB; Caudle WM; Perez XA; Reaney SH; Paletzki R; Isla MZ; Chou VP; McCormack AL; Miller GW; Langston JW; Gerfen CR; Dimonte DA
    Neurobiol Dis; 2007 Aug; 27(2):141-50. PubMed ID: 17560790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL/6 mice.
    Muroyama A; Kobayashi S; Mitsumoto Y
    Neurosci Res; 2011 Apr; 69(4):352-5. PubMed ID: 21185886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
    Paterna JC; Leng A; Weber E; Feldon J; Büeler H
    Mol Ther; 2007 Apr; 15(4):698-704. PubMed ID: 17299411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice.
    Nguyen TA; Frank-Cannon T; Martinez TN; Ruhn KA; Marvin M; Casey B; Treviño I; Hong JJ; Goldberg MS; Tansey MG
    J Neuroinflammation; 2013 Apr; 10():50. PubMed ID: 23622116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
    Goldberg MS; Pisani A; Haburcak M; Vortherms TA; Kitada T; Costa C; Tong Y; Martella G; Tscherter A; Martins A; Bernardi G; Roth BL; Pothos EN; Calabresi P; Shen J
    Neuron; 2005 Feb; 45(4):489-96. PubMed ID: 15721235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.
    Hennis MR; Seamans KW; Marvin MA; Casey BH; Goldberg MS
    PLoS One; 2013; 8(12):e84894. PubMed ID: 24386432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.
    Kim RH; Smith PD; Aleyasin H; Hayley S; Mount MP; Pownall S; Wakeham A; You-Ten AJ; Kalia SK; Horne P; Westaway D; Lozano AM; Anisman H; Park DS; Mak TW
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5215-20. PubMed ID: 15784737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase.
    Pisani A; Martella G; Tscherter A; Costa C; Mercuri NB; Bernardi G; Shen J; Calabresi P
    Neurobiol Dis; 2006 Jul; 23(1):54-60. PubMed ID: 16624565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice.
    Chien CH; Lee MJ; Liou HC; Liou HH; Fu WM
    PLoS One; 2016; 11(3):e0151569. PubMed ID: 26982707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
    Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
    Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat.
    Barc S; Page G; Barrier L; Garreau L; Guilloteau D; Fauconneau B; Chalon S
    J Neurochem; 2002 Feb; 80(3):365-74. PubMed ID: 11905985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigrostriatal cell firing action on the dopamine transporter.
    Rodriguez M; Gonzalez S; Morales I; Sabate M; Gonzalez-Hernandez T; Gonzalez-Mora JL
    Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments.
    Pham TT; Giesert F; Röthig A; Floss T; Kallnik M; Weindl K; Hölter SM; Ahting U; Prokisch H; Becker L; Klopstock T; Hrabé de Angelis M; Beyer K; Görner K; Kahle PJ; Vogt Weisenhorn DM; Wurst W
    Genes Brain Behav; 2010 Apr; 9(3):305-17. PubMed ID: 20039949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
    J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental modeling of functional deficiency of the nigrostriatal dopaminergic system in mice].
    Kozina EA; Khaindrava VG; Kudrin VS; Kucherianu VG; Klodt PD; Bocharov EV; Raevskiĭ KS; Kryzhanovskiĭ GN; Ugriumov MV
    Ross Fiziol Zh Im I M Sechenova; 2010 Mar; 96(3):270-82. PubMed ID: 20535997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.